Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncoimmunology|December 26, 2022
Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumorsPierre-Antoine Laurent, Daphne Morel, Lydia Meziani, et al.
Cancers|June 23, 2019
The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune ResponseJihane Boustani, Mathieu Grapin, Pierre-Antoine Laurent, et al.
Journal for Immunotherapy of Cancer|June 3, 2023
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulationLydia Meziani, Marine Gerbé de Thoré, Céline Clémenson, et al.
Cancer Metastasis Reviews|November 1, 2025
Towards a personalized utilization of stereotactic body radiotherapy for the management of liver metastases in solid tumorsPierre-Antoine Laurent, Kanta Ka, Matthieu Roulleaux Dugage, et al.
Physics in Medicine and Biology|July 22, 2025
GAN-based standardization of MR images: a promising approach for the development of multicentre radiomic modelsStéphane Niyoteka, Rahimeh Rouhi, Pierre-Antoine Laurent, et al.
Journal of Translational Medicine|November 1, 2023
KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partnerPierre-Antoine Laurent, Marina Milic, Clément Quevrin, et al.
Journal of Translational Medicine|March 24, 2025
Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancerHélène Burckel, Anaïs Nicol, Carole Mura, et al.
Journal for Immunotherapy of Cancer|June 27, 2019
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combinationMathieu Grapin, Corentin Richard, Emeric Limagne, et al.
Physics and Imaging in Radiation Oncology|June 24, 2024
Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancerRahimeh Rouhi, Stéphane Niyoteka, Alexandre Carré, et al.
Journal for Immunotherapy of Cancer|October 28, 2022
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapyRoger Sun, Marvin Lerousseau, Jade Briend-Diop, et al.
Pageof 2